PRIMACY IMMUNE THROMBOCYTOPENIA

Clinical trials for PRIMACY IMMUNE THROMBOCYTOPENIA explained in plain language.

Never miss a new study

Get alerted when new PRIMACY IMMUNE THROMBOCYTOPENIA trials appear

Sign up with your email to follow new studies for PRIMACY IMMUNE THROMBOCYTOPENIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New hope for patients whose blood disorder Won't respond to standard pills

Disease control Recruiting now

This study is testing whether combining two existing drugs can help adults with a rare blood disorder called immune thrombocytopenia (ITP) when standard oral medications have failed. All 30 participants will receive weekly infusions of one drug and weekly injections of another, w…

Matched conditions: PRIMACY IMMUNE THROMBOCYTOPENIA

Phase: NA • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control

Last updated Mar 25, 2026 14:08 UTC

PRIMACY IMMUNE THROMBOCYTOPENIA

Get alerted when new PRIMACY IMMUNE THROMBOCYTOPENIA trials appear

New hope for patients whose blood disorder Won't respond to standard pills